Literature DB >> 20008597

Use of oseltamivir in children.

Blake Jamieson1, Rini Jain, Bruce Carleton, Ran D Goldman.   

Abstract

QUESTION: Because of the recent outbreak of pandemic H1N1 2009, I am anticipating a large number of children with influenza-like symptoms or children diagnosed with influenza. Is oseltamivir effective and safe when used for children? ANSWER: Oseltamivir is effective for prevention of complications associated with influenza A (including H1N1) in children. Oseltamivir also reduces the duration of influenza by a median of 36 hours, with nausea and vomiting as the primary reported adverse effects. The World Health Organization recommends oseltamivir as first-line treatment for H1N1, with the use of zanamivir only for suspected or confirmed oseltamivir resistance. Recently, in preparation for the influenza A (H1N1) 2009 pandemic, Health Canada published an interim order permitting the expanded use of oseltamivir for treatment or prophylaxis for children younger than 1 year of age.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20008597      PMCID: PMC2793223     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  12 in total

1.  Experience with oseltamivir for infants younger than 1 year old in Japan.

Authors:  Shigeru Okamoto; Ichiro Kamiya; Kenji Kishida; Tetsuro Shimakawa; Tsuguya Fukui; Takeshi Morimoto
Journal:  Pediatr Infect Dis J       Date:  2005-06       Impact factor: 2.129

2.  Impact of influenza virus infection as a cause of pediatric hospitalization.

Authors:  N Sugaya; K Nerome; M Ishida; R Nerome; M Nagae; Y Takeuchi; M Osano
Journal:  J Infect Dis       Date:  1992-02       Impact factor: 5.226

3.  Tamiflu and neuropsychiatric disturbance in adolescents.

Authors:  Simon R J Maxwell
Journal:  BMJ       Date:  2007-06-16

4.  Policy statement--recommendations for the prevention and treatment of influenza in children, 2009 -2010.

Authors: 
Journal:  Pediatrics       Date:  2009-09-07       Impact factor: 7.124

5.  Update: drug susceptibility of swine-origin influenza A (H1N1) viruses, April 2009.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2009-05-01       Impact factor: 17.586

Review 6.  Vaccines for preventing influenza in healthy adults.

Authors:  V Demicheli; D Rivetti; J J Deeks; T O Jefferson
Journal:  Cochrane Database Syst Rev       Date:  2004

7.  Incidence of neuropsychiatric adverse events in influenza patients treated with oseltamivir or no antiviral treatment.

Authors:  J R Smith; S Sacks
Journal:  Int J Clin Pract       Date:  2009-04       Impact factor: 2.503

Review 8.  Assessment of neuropsychiatric adverse events in influenza patients treated with oseltamivir: a comprehensive review.

Authors:  Stephen Toovey; Craig Rayner; Eric Prinssen; Tom Chu; Barbara Donner; Bharat Thakrar; Regina Dutkowski; Gerhard Hoffmann; Alexander Breidenbach; Lothar Lindemann; Ellen Carey; Lauren Boak; Ronald Gieschke; Susan Sacks; Jonathan Solsky; Ian Small; David Reddy
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

Review 9.  Neuraminidase inhibitors for preventing and treating influenza in children.

Authors:  N J Matheson; A R Harnden; R Perera; A Sheikh; M Symmonds-Abrahams
Journal:  Cochrane Database Syst Rev       Date:  2007-01-24

Review 10.  Towards a sane and rational approach to management of Influenza H1N1 2009.

Authors:  William R Gallaher
Journal:  Virol J       Date:  2009-05-07       Impact factor: 4.099

View more
  4 in total

Review 1.  Influenza and the use of oseltamivir in children.

Authors:  Ergin Çiftçi; Adem Karbuz; Tanıl Kendirli
Journal:  Turk Pediatri Ars       Date:  2016-06-01

2.  Oseltamivir (tamiflu) induced depressive episode in a female adolescent.

Authors:  Sungho Chung; Yoo Sook Joung
Journal:  Psychiatry Investig       Date:  2010-11-11       Impact factor: 2.505

3.  Pandemic influenza 2009: Impact of vaccination coverage on critical illness in children, a Canada and France observational study.

Authors:  Olivier Fléchelles; Olivier Brissaud; Robert Fowler; Thierry Ducruet; Philippe Jouvet
Journal:  World J Clin Pediatr       Date:  2016-11-08

Review 4.  The value of neuraminidase inhibitors for the prevention and treatment of seasonal influenza: a systematic review of systematic reviews.

Authors:  Barbara Michiels; Karolien Van Puyenbroeck; Veronique Verhoeven; Etienne Vermeire; Samuel Coenen
Journal:  PLoS One       Date:  2013-04-02       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.